Skip to main content
Lori Goldstein, MD, Oncology, Philadelphia, PA

LoriJGoldsteinMD

Oncology Philadelphia, PA

Breast Cancer, Hematologic Oncology

Professor of Medicine, Temple University

Dr. Goldstein is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Goldstein's full profile

Already have an account?

  • Office

    333 Cottman Ave
    # Fox
    Philadelphia, PA 19111
    Phone+1 215-728-6900
    Fax+1 215-728-3639

Education & Training

  • National Institutes of Health Clinical Center
    National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1986 - 1989
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1985 - 1986
  • UPMC Medical Education
    UPMC Medical EducationResidency, Internal Medicine, 1982 - 1985
  • SUNY Upstate Medical University
    SUNY Upstate Medical UniversityClass of 1982
  • University of Pennsylvania
    University of PennsylvaniaBA, Molecular Biology, Cum Laude; Brownlee Award, 1974 - 1978

Certifications & Licensure

  • PA State Medical License
    PA State Medical License 1983 - 2024
  • MD State Medical License
    MD State Medical License 1986 - 1992
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

  • Philadelphia Magazine Castle Connolly, 2004-2014
  • America's Top Doctors Castle Connolly, 2002-2014
  • America's Top Doctors for Cancer Castle Connolly, 2005-2013
  • Join now to see all

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • In Support of CDK4/6 Inhibitors—A Meta-Analysis of Available Randomized Data  
    Lori Goldstein, MD, JAMA Network Open

Press Mentions

  • 1 NCCN Guidelines for Patients® Inflammatory Breast Cancer, 2023
    1 NCCN Guidelines for Patients® Inflammatory Breast Cancer, 2023March 23rd, 2023
  • Gene-Expression Profiling Raises Costs for Cancer Care Without Improving Outcomes for Low-Risk Breast Cancer Patients, According to Researchers
    Gene-Expression Profiling Raises Costs for Cancer Care Without Improving Outcomes for Low-Risk Breast Cancer Patients, According to ResearchersJanuary 22nd, 2019

Grant Support

  • Eastern Cooperative Oncology GroupNational Cancer Institute2003–2011
  • Development Of Breast Cancer Research Program At FcccNational Cancer Institute1994
  • Breast, Prostate, Ovarian And Cervical CancerNational Cancer Institute1993

Professional Memberships